Disclosures for "Comparison of MK-6240 and Flortaucipir Tau PET for the Biological Staging of Alzheimer Disease"
-
Dr. Scop Medeiros has nothing to disclose.
-
Dr. Lukasewicz Ferreira has nothing to disclose.
-
Dr. Bellaver has nothing to disclose.
-
Dr. Ruppert has nothing to disclose.
-
Dr. Zalzale has nothing to disclose.
-
Dr. Soares has nothing to disclose.
-
Dr. Bauer-Negrini has nothing to disclose.
-
Dr. Povala has nothing to disclose.
-
Mrs. Silva do Amaral has nothing to disclose.
-
Ms. Lussier has nothing to disclose.
-
Dr. Tudorascu has nothing to disclose.
-
Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
-
Dr. Soleimani-Meigooni has nothing to disclose.
-
Dr. Fortea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Inmune. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Fortea has received research support from NIH. Dr. Fortea has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
-
The institution of Dr. Oh has received research support from NIH.
-
The institution of Prof. Pascual has received research support from NIH. The institution of Prof. Pascual has received research support from NIH.
-
Dr. Gordon has nothing to disclose.
-
Dr. Rosa Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk.
-
Dr. PORCELLO SCHILLING has nothing to disclose.
-
The institution of Miss Baker has received research support from National Institute of Health.
-
Dr. Pascoal has nothing to disclose.